LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy.
复制标题
DOI:
10.1007/s00401-013-1188-4
复制
发表时间:
2013-12
影响因子:
12.7
通讯作者:
Lewis J
中科院分区:
文献类型:
--
作者:
Bailey RM;Covy JP;Melrose HL;Rousseau L;Watkinson R;Knight J;Miles S;Farrer MJ;Dickson DW;Giasson BI;Lewis J
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most frequent cause of familial Parkinson’s disease (PD). The neuropathology of LRRK2-related PD is heterogeneous and can include aberrant tau phosphorylation or neurofibrillary tau pathology. Recently, LRRK2 has been shown to phosphorylate tau in vitro; however, the major epitopes phosphorylated by LRRK2 and the physiological or pathogenic consequences of these modifications in vivo are unknown. Using mass spectrometry, we identified multiple sites on recombinant tau that are phosphorylated by LRRK2 in vitro, including pT149 and pT153, which are phospho-epitopes that to date have been largely unexplored. Importantly, we demonstrate that expression of transgenic LRRK2 in a mouse model of tauopathy increased the aggregation of insoluble tau and its phosphorylation at T149, T153, T205, and S199/S202/T205 epitopes. These findings indicate that tau can be a LRRK2 substrate and that this interaction can enhance salient features of human disease. The online version of this article (doi:10.1007/s00401-013-1188-4) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
8.6
作者:
Covy, Jason P.;Yuan, Wuxing;Waxman, Elisa A.;Hurtig, Howard I.;Van Deerlin, Vivianna M.;Giasson, Benoit I.
通讯作者:
Giasson, Benoit I.
影响因子:
56.9
作者:
Hong, M;Zhukareva, V;Lee, VMY
通讯作者:
Lee, VMY
影响因子:
3.5
作者:
Hasegawa, M;Smith, MJ;Goedert, M
通讯作者:
Goedert, M
影响因子:
3.9
作者:
Cookson, Mark R.
通讯作者:
Cookson, Mark R.
影响因子:
11
作者:
Gaig, Carles;Marti, Maria Jose;Tolosa, Eduardo
通讯作者:
Tolosa, Eduardo